Low-Dose Interleukin-2 Altered Gut Microbiota and Ameliorated Collagen-Induced Arthritis

References

• Zhang SX, Wang J, Wang CH, et al. Low-dose IL-2 therapy limits the reduction in absolute numbers of circulating regulatory T cells in rheumatoid arthritis. Ther Adv Musculoskelet Dis. 2021;13:1759720X211011370. doi:10.1177/1759720X211011370
   PubMedGoogle Scholar
• Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388(10055):2023–2038. Epub 2016 May 3. Erratum in: Lancet. 2016 Oct 22;388(10055):1984. doi:10.1016/S0140-6736(16)30173-8
   PubMed Web of Science ®Google Scholar
• Zhu H, Li R, Da Z, et al. Remission assessment of rheumatoid arthritis in daily practice in China: a cross-sectional observational study. Clin Rheumatol. 2018;37(3):597–605. doi:10.1007/s10067-017-3850-z
   PubMed Web of Science ®Google Scholar
• Fraenkel L, Bathon JM, England BR, et al. 2021 American college of rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Care Res. 2021;73(7):924–939. doi:10.1002/acr.24596
   PubMed Web of Science ®Google Scholar
• Wang W, Zhou H, Liu L. Side effects of methotrexate therapy for rheumatoid arthritis: a systematic review. Eur J Med Chem. 2018;158:502–516. doi:10.1016/j.ejmech.2018.09.027
   PubMed Web of Science ®Google Scholar
• Friedman B, Cronstein B. Methotrexate mechanism in treatment of rheumatoid arthritis. Joint Bone Spine. 2019;86(3):301–307. PMID: 30081197. doi:10.1016/j.jbspin.2018.07.004
   PubMed Web of Science ®Google Scholar
• Hyndman IJ. Rheumatoid arthritis: past, present and future approaches to treating the disease. Int J Rheum Dis. 2017;20(4):417–419. doi:10.1111/1756-185X.12823
   PubMed Web of Science ®Google Scholar
• Ehrenstein MR, Evans JG, Singh A, et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med. 2004;200(3):277–285. doi:10.1084/jem.20040165
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Mikami N, Wing JB, et al. Regulatory T cells and human disease. Annu Rev Immunol. 2020;38:541–566. doi:10.1146/annurev-immunol-042718-041717
   PubMed Web of Science ®Google Scholar
• Zhang SX, Ma XW, Li YF, et al. The proportion of regulatory T cells in patients with systemic lupus erythematosus: a meta-analysis. J Immunol Res. 2018;2018:7103219. doi:10.1155/2018/7103219
   PubMed Web of Science ®Google Scholar
• Miao M, Hao Z, Guo Y, et al. Short-term and low-dose IL-2 therapy restores the Th17/Treg balance in the peripheral blood of patients with primary Sjögren’s syndrome. Ann Rheum Dis. 2018;77(12):1838–1840. doi:10.1136/annrheumdis-2018-213036
   PubMed Web of Science ®Google Scholar
• Paradowska-Gorycka A, Wajda A, Romanowska-Próchnicka K, et al. Th17/Treg-related transcriptional factor expression and cytokine profile in patients with rheumatoid arthritis. Front Immunol. 2020;11:572858. doi:10.3389/fimmu.2020.572858
   PubMed Web of Science ®Google Scholar
• Savage PA, Klawon DEJ, Miller CH. Regulatory T cell development. Annu Rev Immunol. 2020;38:421–453. doi:10.1146/annurev-immunol-100219-020937
   PubMed Web of Science ®Google Scholar
• Dominguez-Villar M, Hafler DA. Regulatory T cells in autoimmune disease. Nat Immunol. 2018;19(7):665–673. doi:10.1038/s41590-018-0120-4
   PubMed Web of Science ®Google Scholar
• Owen DL, Sjaastad LE, Farrar MA. Regulatory T cell development in the thymus. J Immunol. 2019;203(8):2031–2041. doi:10.4049/jimmunol.1900662
   PubMed Web of Science ®Google Scholar
• Klatzmann D, Abbas AK. The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases. Nat Rev Immunol. 2015;15(5):283–294. doi:10.1038/nri3823
   PubMed Web of Science ®Google Scholar
• Yokoyama Y, Iwasaki T, Kitano S, et al. IL-2-Anti-IL-2 monoclonal antibody immune complexes inhibit collagen-induced arthritis by augmenting regulatory T cell functions. J Immunol. 2018;201(7):1899–1906. doi:10.4049/jimmunol.1701502
   PubMed Web of Science ®Google Scholar
• Wu R, Li N, Zhao X, et al. Low-dose Interleukin-2: biology and therapeutic prospects in rheumatoid arthritis. Autoimmun Rev. 2020;19(10):102645. doi:10.1016/j.autrev.2020.102645
   PubMed Web of Science ®Google Scholar
• Zhang R, Miao J, Zhu P. Regulatory T cell heterogeneity and therapy in autoimmune diseases. Autoimmun Rev. 2021;20(5):102715. doi:10.1016/j.autrev.2020.102715
   PubMed Web of Science ®Google Scholar
• He J, Zhang X, Wei Y, et al. Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosus. Nat Med. 2016;22(9):991–993. doi:10.1038/nm.4148
   PubMed Web of Science ®Google Scholar
• Holers VM, Demoruelle MK, Kuhn KA, et al. Rheumatoid arthritis and the mucosal origins hypothesis: protection turns to destruction. Nat Rev Rheumatol. 2018;14(9):542–557. doi:10.1038/s41584-018-0070-0
   PubMed Web of Science ®Google Scholar
• Bennike TB, Ellingsen T, Glerup H, et al. Proteome analysis of rheumatoid arthritis gut mucosa. J Proteome Res. 2017;16(1):346–354. doi:10.1021/acs.jproteome.6b00598
   PubMed Web of Science ®Google Scholar
• Horta-Baas G, Romero-Figueroa MDS, Montiel-Jarquín AJ, et al. Intestinal dysbiosis and rheumatoid arthritis: a link between gut microbiota and the pathogenesis of rheumatoid arthritis. J Immunol Res. 2017;2017:4835189. doi:10.1155/2017/4835189
   PubMed Web of Science ®Google Scholar
• Schluter J, Peled JU, Taylor BP, et al. The gut microbiota is associated with immune cell dynamics in humans. Nature. 2020;588(7837):303–307. doi:10.1038/s41586-020-2971-8
   PubMed Web of Science ®Google Scholar
• Shi N, Li N, Duan X, et al. Interaction between the gut microbiome and mucosal immune system. Mil Med Res. 2017;4:14. doi:10.1186/s40779-017-0122-9
   PubMed Web of Science ®Google Scholar
• Reyes-Castillo Z, Valdés-Miramontes E, Llamas-Covarrubias M, et al. Troublesome friends within us: the role of gut microbiota on rheumatoid arthritis etiopathogenesis and its clinical and therapeutic relevance. Clin Exp Med. 2021;21(1):1–13. doi:10.1007/s10238-020-00647-y
   PubMed Web of Science ®Google Scholar
• Lee N, Kim WU. Microbiota in T-cell homeostasis and inflammatory diseases. Exp Mol Med. 2017;49(5):e340. doi:10.1038/emm.2017.36
   PubMed Web of Science ®Google Scholar
• Lee JY, Mannaa M, Kim Y, et al. Comparative analysis of fecal microbiota composition between rheumatoid arthritis and osteoarthritis patients. Genes. 2019;10(10):748. doi:10.3390/genes10100748
   PubMed Web of Science ®Google Scholar
• Li Y, Zhang SX, Yin XF, et al. The gut microbiota and its relevance to peripheral lymphocyte subpopulations and cytokines in patients with rheumatoid arthritis. J Immunol Res. 2021;2021:6665563. doi:10.1155/2021/6665563
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang D, Jia H, et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med. 2015;21(8):895–905. doi:10.1038/nm.3914
   PubMed Web of Science ®Google Scholar
• Pol JG, Caudana P, Paillet J, Piaggio E, Kroemer G. Effects of interleukin-2 in immunostimulation and immunosuppression. J Exp Med. 2020;217(1):e20191247. PMID: 31611250; PMCID: PMC7037245. doi:10.1084/jem.20191247
   PubMed Web of Science ®Google Scholar
• Delville M, Bellier F, Leon J, et al. A combination of cyclophosphamide and interleukin-2 allows CD4+ T cells converted to Tregs to control scurfy syndrome. Blood. 2021;137(17):2326–2336. PMID: 33545713; PMCID: PMC8163490. doi:10.1182/blood.2020009187
   PubMed Web of Science ®Google Scholar
• Thornton S, Boivin GP, Kim KN, Finkelman FD, Hirsch R. Heterogeneous effects of IL-2 on collagen-induced arthritis. J Immunol. 2000;165(3):1557–1563. PMID: 10903764. doi:10.4049/jimmunol.165.3.1557
   PubMed Web of Science ®Google Scholar
• Miyoshi M, Liu S. Collagen-induced arthritis models. Methods Mol Biol. 2018;1868:3–7. doi:10.1007/978-1-4939-8802-0_1
   PubMedGoogle Scholar
• Wang T, Jia Q, Chen T, et al. Alleviation of synovial inflammation of Juanbi-Tang on collagen-induced arthritis and TNF-Tg mice model. Front Pharmacol. 2020;11:45. doi:10.3389/fphar.2020.00045
   PubMed Web of Science ®Google Scholar
• Tu Y, Wang K, Liang Y, et al. Glycine tabacina ethanol extract ameliorates collagen-induced arthritis in rats via inhibiting pro-inflammatory cytokines and oxidation. J Ethnopharmacol. 2019;237:20–27. doi:10.1016/j.jep.2019.03.035
   PubMed Web of Science ®Google Scholar
• Ma X, Chen G, Wang J, et al. Pedunculoside attenuates pathological phenotypes of fibroblast-like synoviocytes and protects against collagen-induced arthritis. Scand J Rheumatol. 2019;48(5):383–392. doi:10.1080/03009742.2019.1600716
   PubMed Web of Science ®Google Scholar
• Chen HL, Lin SC, Li S, Tang KT, Lin CC. Alantolactone alleviates collagen-induced arthritis and inhibits Th17 cell differentiation through modulation of STAT3 signalling. Pharm Biol. 2021;59(1):134–145. PMID: 33556301. doi:10.1080/13880209.2021.1876102
   PubMed Web of Science ®Google Scholar
• Hui W, Yu D, Cao Z, Zhao X. Butyrate inhibit collagen-induced arthritis via Treg/IL-10/Th17 axis. Int Immunopharmacol. 2019;68:226–233. PMID: 30660077. doi:10.1016/j.intimp.2019.01.018
   PubMed Web of Science ®Google Scholar
• Kim M, Choe Y, Lee H, et al. Blockade of translationally controlled tumor protein attenuated the aggressiveness of fibroblast-like synoviocytes and ameliorated collagen-induced arthritis. Exp Mol Med. 2021;53(1):67–80. doi:10.1038/s12276-020-00546-y
   PubMed Web of Science ®Google Scholar
• Zhang S, Wang H, Zhu MJ. A sensitive GC/MS detection method for analyzing microbial metabolites short chain fatty acids in fecal and serum samples. Talanta. 2019;196:249–254. doi:10.1016/j.talanta.2018.12.049
   PubMed Web of Science ®Google Scholar
• Liu Y, Jin X, Hong HG, et al. The relationship between gut microbiota and short chain fatty acids in the renal calcium oxalate stones disease. FASEB J. 2020;34(8):11200–11214. doi:10.1096/fj.202000786R
   PubMed Web of Science ®Google Scholar
• Byndloss MX, Olsan EE, Rivera-Chávez F, et al. Microbiota-activated PPAR-γ signaling inhibits dysbiotic Enterobacteriaceae expansion. Science. 2017;357(6351):570–575. PMID: 28798125. doi:10.1126/science.aam9949
   PubMed Web of Science ®Google Scholar
• Morrison PK, Newbold CJ, Jones E, et al. The equine gastrointestinal microbiome: impacts of weight-loss. BMC Vet Res. 2020;16(1):78. doi:10.1186/s12917-020-02295-6
   PubMed Web of Science ®Google Scholar
• Cornejo-Granados F, Gallardo-Becerra L, Leonardo-Reza M, et al. A meta-analysis reveals the environmental and host factors shaping the structure and function of the shrimp microbiota. PeerJ. 2018;6:e5382. doi:10.7717/peerj.5382
   PubMed Web of Science ®Google Scholar
• Lozupone C, Knight R. UniFrac: a new phylogenetic method for comparing microbial communities. Appl Environ Microbiol. 2005;71(12):8228–8235. doi:10.1128/AEM.71.12.8228-8235.2005
   PubMed Web of Science ®Google Scholar
• Dhakal S, McCormack L, Dey M. Association of the gut microbiota with weight-loss response within a retail weight-management program. Microorganisms. 2020;8(8):1246. doi:10.3390/microorganisms8081246
   PubMed Web of Science ®Google Scholar
• Tao JH, Cheng M, Tang JP, et al. Foxp3, regulatory T cell, and autoimmune diseases. Inflammation. 2017;40(1):328–339. doi:10.1007/s10753-016-0470-8
   PubMed Web of Science ®Google Scholar
• Weyand CM, Goronzy JJ. The immunology of rheumatoid arthritis. Nat Immunol. 2021;22(1):10–18. doi:10.1038/s41590-020-00816-x
   PubMed Web of Science ®Google Scholar
• Abbas AK, Trotta E, R Simeonov D, et al. Revisiting IL-2: biology and therapeutic prospects. Sci Immunol. 2018;3(25):eaat1482. doi:10.1126/sciimmunol.aat1482.
   PubMed Web of Science ®Google Scholar
• Liu X, Zeng B, Zhang J, et al. Role of the gut microbiome in modulating arthritis progression in mice. Sci Rep. 2016;6:30594. doi:10.1038/srep30594
   PubMed Web of Science ®Google Scholar
• Maeda Y, Takeda K. Role of gut microbiota in rheumatoid arthritis. J Clin Med. 2017;6(6):60. doi:10.3390/jcm6060060
   PubMed Web of Science ®Google Scholar
• Toivanen P, Vartiainen S, Jalava J, et al. Intestinal anaerobic bacteria in early rheumatoid arthritis (RA), Arthritis Research, vol. 4, p. 5; 2002.
   Google Scholar
• Du Q, Liu XH, Tian K, et al. Analysis of periodontal status and salivary microbial diversity in patients with rheumatoid arthritis. Sichuan Da Xue Xue Bao Yi Xue Ban. 2019;50(6):935–940. Chinese.
   PubMedGoogle Scholar
• Liu X, Zou Q, Zeng B, et al. Analysis of fecal Lactobacillus community structure in patients with early rheumatoid arthritis. Curr Microbiol. 2013;67(2):170–176. doi:10.1007/s00284-013-0338-1
   PubMed Web of Science ®Google Scholar
• Zhang L, Song P, Zhang X, et al. Alpha-glucosidase inhibitors alter gut microbiota and ameliorate collagen-induced arthritis. Front Pharmacol. 2020;10:1684. doi:10.3389/fphar.2019.01684
   PubMed Web of Science ®Google Scholar
• Qiao S, Lian X, Yue M, et al. Regulation of gut microbiota substantially contributes to the induction of intestinal Treg cells and consequent anti-arthritis effect of madecassoside. Int Immunopharmacol. 2020;89(Pt A):107047. doi:10.1016/j.intimp.2020.107047
   PubMed Web of Science ®Google Scholar
• Brown EM, Kenny DJ, Xavier RJ. Gut microbiota regulation of T cells during inflammation and autoimmunity. Annu Rev Immunol. 2019;37:599–624. doi:10.1146/annurev-immunol-042718-041841
   PubMed Web of Science ®Google Scholar
• Shan J, Peng L, Qian W, et al. Integrated serum and fecal metabolomics study of collagen-induced arthritis rats and the therapeutic effects of the zushima tablet. Front Pharmacol. 2018;9:891. doi:10.3389/fphar.2018.00891
   PubMed Web of Science ®Google Scholar
• Sun M, Wu W, Chen L, et al. Microbiota-derived short-chain fatty acids promote Th1 cell IL-10 production to maintain intestinal homeostasis. Nat Commun. 2018;9(1):3555. doi:10.1038/s41467-018-05901-2
   PubMed Web of Science ®Google Scholar
• Park J, Kim M, Kang SG, et al. Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway. Mucosal Immunol. 2015;8(1):80–93. doi:10.1038/mi.2014.44
   PubMed Web of Science ®Google Scholar
• Luu M, Visekruna A. Short-chain fatty acids: bacterial messengers modulating the immunometabolism of T cells. Eur J Immunol. 2019;49(6):842–848. doi:10.1002/eji.201848009
   PubMed Web of Science ®Google Scholar
• Mizuno M, Noto D, Kaga N, et al. The dual role of short fatty acid chains in the pathogenesis of autoimmune disease models. PLoS One. 2017;12(2):e0173032. doi:10.1371/journal.pone.0173032
   PubMed Web of Science ®Google Scholar
• Koh A, De Vadder F, Kovatcheva-Datchary P, et al. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell. 2016;165(6):1332–1345. doi:10.1016/j.cell.2016.05.041
   PubMed Web of Science ®Google Scholar